Eosinophilic Esophagitis (EoE) Clinical Trial
Official title:
Bethanechol for Treatment of Eosinophilic Esophagitis (EoE)
The primary goals of this study are to ease the symptoms of patients with Eosinophilic Esophagitis (EoE) and to test the effectiveness of the drug bethanechol in relieving those symptoms.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04394351 -
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
|
Phase 3 | |
| Terminated |
NCT03245840 -
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)
|
Phase 3 | |
| Completed |
NCT03581838 -
Eating With Eosinophilic Esophagitis (EoE)
|
||
| Completed |
NCT02778867 -
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
|
Phase 2/Phase 3 | |
| Completed |
NCT01642212 -
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
|
Phase 2 | |
| Completed |
NCT05485779 -
SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04626609 -
Prostaglandin and Cannabinoid Receptors in EoE
|
||
| Completed |
NCT00762073 -
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis
|
Phase 2 | |
| Completed |
NCT02605837 -
A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
|
Phase 3 | |
| Completed |
NCT02320981 -
Mucosal Impedance in Pediatric Population
|
N/A | |
| Recruiting |
NCT06389994 -
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
|
||
| Completed |
NCT02736409 -
An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
|
Phase 3 |